6 recruiting, 2 not yet recruiting, 2 withdrawn, 1 completed. 2 Not applicable, 1 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Not yet recruiting 2 |
| Phase 2 | 1 | Terminated 1 |
| Phase 4 | 1 | Withdrawn 1 |
Follow ABPA: new trials by email Literature Review of ABPA trials Research Report on ABPA
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Real-World Effectiveness of Depemokimab in Allergic Bronchopulmonary Aspergillosis With Severe Eosinophilic Asthma Depemokimab - Allergic Bronchopulmonary Aspergillosis, ABPA | Not applicable | Not yet recruiting | Qianfoshan Hospital | 10 | 2026-11-01 | 2026-09-24 |
| Real-World Effectiveness of Tezepelumab in Allergic Bronchopulmonary Aspergillosis Tezepelumab - Allergic Bronchopulmonary Aspergillosis, Severe Asthma | Not applicable | Not yet recruiting | Qianfoshan Hospital | 10 | 2026-09-01 | 2026-08-11 |
| A Study of the Efficacy and Safety of Bronchoscopic Airway Clearance and Amphotericin B Spraying in Patients With ABPA The patients were treated with bronchoscopic airway clearance and amphotericin B spraying - ABPA, Allergic Bronchopulmonary Aspergillosis | Recruiting | Qianfoshan Hospital | 44 | 2026-01-10 | 2026-01-23 | |
| Real-World Effectiveness of Benralizumab in Allergic Bronchopulmonary Aspergillosis Fasenra - Allergic Bronchopulmonary Aspergillosis, Severe Asthma | Recruiting | Qianfoshan Hospital | 20 | 2025-09-01 | 2026-04-21 | |
| Effects of Environmental Fungal Exposure on Bronchial Asthma, ABPA and Bronchiectasis Environmental Exposure, Asthma | Recruiting | First Affiliated Hospital of Ningbo University | 125 | 2025-07-23 | 2026-01-02 | |
| Fungal Status and Prognosis in ABPA ABPA, Allergic Bronchopulmonary Aspergillosis | Recruiting | Qianfoshan Hospital | 114 | 2025-07-01 | 2026-07-08 | |
| A Cohort Study of the Efficacy and Safety of Biologics in Patients With ABPA Biologic Agent - ABPA, Biologics | Recruiting | Qianfoshan Hospital | 50 | 2025-01-31 | 2026-04-17 | |
| Allergic Bronchopulmonary Aspergillosis Prescreening Study Allergic Bronchopulmonary Aspergillosis, Asthma | Withdrawn | Community Pharmacology Services Ltd | 2024-01-10 | 2024-01-16 | ||
| Study to Evaluate Itraconazole Administered as Inhaled Dry Powder in Adults With Asthma and ABPA Itraconazole Powder, Placebo - ABPA | Phase 2 | Terminated | Pulmatrix Inc. | 8 | 2023-02-01 | 2024-04-02 |
| ML-Based ABPA Recurrence Prediction and Clinical Utility ABPA, Allergic Bronchopulmonary Aspergillosis | Recruiting | Qianfoshan Hospital | 200 | 2021-01-01 | 2026-07-20 | |
| Benralizumab in the Treatment of Patients With Severe Asthma With ABPA Fasenra, 30 Mg/mL Subcutaneous Solution - ABPA, Severe Asthma | Phase 4 | Withdrawn | Baylor Research Institute | 2019-12-23 | 2022-02-01 | |
| Cytokine Profile of Allergic Bronchopulmonary Aspergillosis ABPA | Unknown | Shanghai Pulmonary Hospital, Shanghai, China | 100 | 2014-12-01 | 2021-03-23 | |
| Lung MRI and Allergic Broncho-pulmonary Aspergillosis in Cystic Fibrosis Pulmonary Cystic Fibrosis, ABPA | Completed | Hôpital Haut Lévêque | 240 | 2014-01-01 | 2023-03-07 |
Aspergillosis, Allergic Bronchopulmonary (10) · Asthma (6) · Bronchiectasis (2) · Invasive Pulmonary Aspergillosis (2) · Cystic Fibrosis (1) · Pulmonary Eosinophilia (1)
Lung Diseases (12) · Respiratory Tract Diseases (12) · Hypersensitivity (11) · Hypersensitivity, Immediate (11) · Immune System Diseases (11) · Respiratory Hypersensitivity (11) · Aspergillosis (10) · Bacterial Infections and Mycoses (10) · Infections (10) · Lung Diseases, Fungal (10) · Mycoses (10) · Pulmonary Aspergillosis (10) · Respiratory Tract Infections (10) · Bronchial Diseases (7) · Lung Diseases, Obstructive (6)
benralizumab (2) · Biological Factors (1) · tezepelumab (1)
Qianfoshan Hospital (7) · Baylor Research Institute (1) · Community Pharmacology Services Ltd (1) · First Affiliated Hospital of Ningbo University (1) · Hôpital Haut Lévêque (1) · Pulmatrix Inc. (1) · Shanghai Pulmonary Hospital, Shanghai, China (1)
China (9) · France (2) · United Kingdom (2) · United States (2) · Australia (1)
Chris Cabell, MD (1) · Jin-fu Xu, MD (1) · Margaret Wasilewski, MD (1) · Qian Qi (1) · Yolanda Mageto, MD (1)